Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Wellbeing Digital Sciences Inc KONEF

Wellbeing Digital Sciences Inc. is an evidence-based mental healthcare company. The Company is focused on the development and implementation of clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. It operates through three segments: Wellbeing & IRP; KGK Science and Mindscape. It operates medical clinics across North America to help its patients access plant-based medicines, psychedelics, and other forms of mental health care, all of which have the potential to heal them of their physical and/or emotional pain. Its subsidiaries include Mindscape Ketamine & Infusions Therapy LLC, KGK Science Inc. and Integrated Rehab and Performance Ltd. It is supported by a network of North American clinics that provide therapies and other types of treatment to patients, as well as through a contract research organization that offers clinical trials services to clients pursuing drug development.


GREY:KONEF - Post by User

Post by StockHawk1on Dec 22, 2021 6:54pm
192 Views
Post# 34256447

$MEDI dips despite solid Q1 22 financials

$MEDI dips despite solid Q1 22 financials

KetamineOne Capital ( $KONEF $MEDI ) took a huge share-price hit today despite reporting strong Q122 financial results recently.


$MEDI Q122  ended October 31st 2021.


Some highlights from the results include: 

- total assets = $19.08M

- revenue = $1. 99M (compaired to $nil for Q121)

- gross profit = $594k (compaired to $nil for Q121)


Full financials here: https://ca.finance.yahoo.com/news/ketamine-one-reports-strong-1q22-080000368.html


$MEDI @ $0.27 (down 28.9% so it is a good opportunity to buy on the cheap) 

MC 27.905M

 
<< Previous
Bullboard Posts
Next >>